WITHDRAWN: Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.

Author: LovellH G

Paper Details 
Original Abstract of the Article :
BACKGROUND: Renal disease is a serious complication of diabetes mellitus. OBJECTIVES: To examine whether the progression of early diabetic renal disease to end-stage renal failure may be slowed by the use of angiotensin converting enzyme inhibitors for reasons other than their antihypertensive prop...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/14651858.CD002183.pub2

データ提供:米国国立医学図書館(NLM)

WITHDRAWN: Angiotensin Converting Enzyme Inhibitors in Normotensive Diabetic Patients with Microalbuminuria

This research examines the potential benefits of angiotensin converting enzyme (ACE) inhibitors in treating normotensive diabetic patients with microalbuminuria, a condition that can progress to kidney failure. The researchers conducted a meta-analysis of 12 randomized controlled trials to assess the effectiveness of ACE inhibitors in slowing the progression of early diabetic renal disease.

The results suggest that ACE inhibitors can reduce albumin excretion rates in normotensive diabetic patients with microalbuminuria, potentially delaying the progression of kidney disease. However, the study acknowledges the need for further research to confirm this effect and to determine whether ACE inhibitors have a direct renal-protective effect or if their benefits are primarily due to their blood pressure lowering properties. It's like a desert explorer carefully observing the impact of a new resource on the surrounding ecosystem.

Navigating the Complexities of Diabetic Kidney Disease

This research sheds light on the potential role of ACE inhibitors in managing diabetic kidney disease, emphasizing the importance of a multi-faceted approach to treatment. It's like a camel navigating through a challenging desert, carefully choosing its path to avoid obstacles.

Protecting Your Kidneys: A Holistic Approach

This study highlights the need for a comprehensive approach to managing diabetic kidney disease, considering both blood pressure control and potential renal-protective effects of medications. It's like a camel using its unique adaptations to survive in the desert, finding balance and resilience.

Dr.Camel's Conclusion

This study provides valuable insights into the potential benefits of ACE inhibitors in treating normotensive diabetic patients with microalbuminuria. It emphasizes the need for continued research to further understand the complex interplay between diabetes, kidney disease, and ACE inhibitors.

Date :
  1. Date Completed 2007-10-18
  2. Date Revised 2020-05-11
Further Info :

Pubmed ID

17636698

DOI: Digital Object Identifier

10.1002/14651858.CD002183.pub2

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.